Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ashraf Abu Jama"'
Autor:
Walid Shalata, Ashraf Abu Jama, Yulia Dudnik, Omar Abu Saleh, Sondos Shalata, Lena Tourkey, Kim Sheva, Amichay Meirovitz, Alexander Yakobson
Publikováno v:
Medicina, Vol 60, Iss 8, p 1270 (2024)
Recent advancements in targeted therapies for non-small-cell lung cancer (NSCLC), specifically focusing on epidermal growth factor receptor (EGFR) mutations, have revolutionized treatment strategies. Osimertinib, an approved therapy for metastatic NS
Externí odkaz:
https://doaj.org/article/833e69e8065c4b8294cd11b9b3ba10b5
Autor:
Walid Shalata, Rachel Steckbeck, Amjad Abu Salman, Omar Abu Saleh, Ashraf Abu Jama, Zoé Gabrielle Attal, Sondos Shalata, Hilmi Alnsasra, Alexander Yakobson
Publikováno v:
Medicina, Vol 60, Iss 2, p 224 (2024)
Patient prognoses have been significantly enhanced by immune checkpoint inhibitors (ICIs), altering the standard of care in cancer treatment. These novel antibodies have become a mainstay of care for metastatic non-small-cell lung cancer (mNSCLC) pat
Externí odkaz:
https://doaj.org/article/74e2eeb3d30440a99b6c3f110a08cd85
Autor:
Walid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, Amjad Abu Salman, Ashraf Abu Jama, Sondos Shalata, Kais Halumi, Alexander Yakobson
Publikováno v:
Medicina, Vol 59, Iss 11, p 1946 (2023)
Many different types of cancer can be treated with immunotherapy drugs called immune checkpoint inhibitors (ICIs). These drugs have altered the landscape of cancer treatment options since they function by triggering a stronger immune response to mali
Externí odkaz:
https://doaj.org/article/b3f700134e9f408c8ce8fb5ca9107664
Autor:
Walid Shalata, Rachel Steckbeck, Ilya Polishchuk, Ahron Yehonatan Cohen, Keren Rouvinov, Margarita Tokar, Ashraf Abu Jama, Omar Abu Saleh, Kim Sheva, Alexander Yakobson
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
This case report describes the occurrence of hyperbilirubinemia as a complication of metastatic melanoma. A 72-year-old male patient was diagnosed with BRAF V600E-mutated melanoma with metastases in the liver, lymph nodes, lungs, pancreas, and stomac
Externí odkaz:
https://doaj.org/article/cffe25d51cba484f9b2a30327de7f0da
Autor:
Walid Shalata, Alexander Yakobson, Rachel Steckbeck, Ashraf Abu Jama, Omar Abu Saleh, Abed Agbarya
Publikováno v:
Current Oncology, Vol 29, Iss 1, Pp 173-177 (2021)
In the following report, we describe a case of alkaline phosphatase (ALP) elevation occurring during treatment with alectinib (Alecensa™), which was administered for anaplastic lymphoma kinase (ALK) mutated metastatic non-small cell lung cancer (mN
Externí odkaz:
https://doaj.org/article/e4788b8ad1924b0bb7f2a16a4e881fe6
Autor:
Walid Shalata, Alexander Yakobson, Yulia Dudnik, Forat Swaid, Mohammad Sheikh Ahmad, Ashraf Abu Jama, Ahron Yehonatan Cohen, Abed Agbarya
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2438 (2023)
Immune checkpoint inhibitors have become the standard of care in the treatment of metastatic non-small-cell lung cancer (NSCLC). The combination of nivolumab plus ipilimumab and chemotherapy has been shown to improve outcomes in terms of overall surv
Externí odkaz:
https://doaj.org/article/d217ee7737284174a6a3d089a1e8cd40
Autor:
Walid Shalata, Ismaell Massalha, Shlomo Yaron Ishay, Elena Chernomordikova, Ashraf Abu Jama, Keren Rouvinov, Yulia Dudnik, Alexander Yakobson
Publikováno v:
Life, Vol 13, Iss 7, p 1585 (2023)
In this particular case study, we present a 66-year-old male who was diagnosed with an atrial myxoma eight years after receiving treatment for non-small cell lung cancer. The patient underwent chemo-radiotherapy (mediastinal area) in 2012 to address
Externí odkaz:
https://doaj.org/article/43fdfc4b6d6e41ebbbb04ee2aadd8f56
Autor:
Walid Shalata, Jeremy Zolnoorian, Amichay Meirovitz, Kim Sheva, Ashraf Abu Jama, Omar Abu Saleh, Alexander Yakobson
Publikováno v:
Life, Vol 13, Iss 1, p 40 (2022)
Dermatomyositis is a rare inflammatory myopathy that is often related to lung cancer. In this retrospective observational study, we analyzed data from patients diagnosed with lung cancer at Soroka University Medical Center between January 2017 and Ju
Externí odkaz:
https://doaj.org/article/20459d2094134273aee8c927d5b83587
Autor:
Walid Shalata, Alexander Yakobson, Rachel Steckbeck, Ashraf Abu Jama, Omar Abu Saleh, Abed Agbarya
Publikováno v:
Current Oncology, Vol 29, Iss 16, Pp 173-177 (2022)
Current Oncology
Current Oncology
In the following report, we describe a case of alkaline phosphatase (ALP) elevation occurring during treatment with alectinib (Alecensa™), which was administered for anaplastic lymphoma kinase (ALK) mutated metastatic non-small cell lung cancer (mN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504fb758efac07eb199a686173bd3b9f
https://www.mdpi.com/1718-7729/29/1/16
https://www.mdpi.com/1718-7729/29/1/16
Autor:
Walid Shalata, Sarah Weissmann, Sapir Itzhaki Gabay, Kim Sheva, Omar Abu Saleh, Ashraf Abu Jama, Alexander Yakobson, Keren Rouvinov
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5451
Immune checkpoint inhibitors are a class of cancer treatment drugs that stimulate the immune system’s ability to fight tumor cells. These drugs are monoclonal antibodies targeting im-mune-inhibiting proteins on cancer cells, such as CTLA-4 and PD-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4323c85d2419b64d30a2550c5edb1618
https://pubmed.ncbi.nlm.nih.gov/36358869
https://pubmed.ncbi.nlm.nih.gov/36358869